Borderline personality disorder (BPD) is a common and debilitating mental health condition, yet medication options remain limited according to a new systematic review published in CNS Drugs. The study found minimal evidence supporting the benefits of medication for BPD beyond some improvement in individual symptoms. No drugs have been approved for BPD and there is …
Mood disorders like major depression and bipolar disorder affect millions worldwide. Existing treatments often fall short, highlighting the need for better options. An emerging possibility is anti-inflammatory drugs like celecoxib that may target the immune system abnormalities linked to these conditions. A new comprehensive review suggests celecoxib holds promise as an add-on treatment for major …
A new network meta-analysis published in Frontiers in Pharmacology provides important insights into the relative efficacy and safety of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) for migraine prevention. This comprehensive analysis compares four CGRP monoclonal antibodies – eptinezumab, erenumab, fremanezumab, and galcanezumab – and sheds light on which ones are most effective for reducing …
Attention-deficit/hyperactivity disorder (ADHD), long thought of as a childhood condition, is increasingly recognized as a disorder that can persist into adulthood. Up to 60% of children with ADHD continue to experience symptoms as adults. Yet treatment options specifically tested and approved for adult ADHD remain limited. A new study published this month in the Journal …
Brain zaps are brief, electric shock-like sensations felt in the brain that can occur when decreasing or stopping dosage of certain antidepressants. Though poorly understood, new research is shedding light on this perplexing phenomenon. Key Facts: Brain zaps are a recently acknowledged potential side effect of discontinuing certain antidepressants like SSRIs and SNRIs. They feel …
Visual snow syndrome (VSS) is a perplexing neurological condition characterized by seeing static-like flickering dots across the entire visual field. While much remains unknown about this rare disorder, research continues to uncover clues about potential causes and treatments. Here are some key facts on the current state of knowledge regarding visual snow: VSS involves seeing …
Posttraumatic stress disorder (PTSD) following a traumatic event like a car accident can be extremely debilitating. New research suggests that virtual reality exposure therapy (VRET) may be an effective treatment option. Key Facts VRET is a form of exposure therapy that uses virtual reality to simulate the traumatic experience in a controlled setting. Two case …
A new study published in Brain Sciences has uncovered important epigenetic differences in a group of Mexican children diagnosed with autism spectrum disorder (ASD) compared to neurotypical controls. The research provides new insights into the complex interplay between genes and environment in ASD, with implications for improving diagnosis and treatment. Key facts: Researchers found 853 …
A new brain imaging study reveals deficits in key networks involved in social functioning among individuals with schizophrenia. The findings shed light on the underlying neural mechanisms that may contribute to impaired social skills in this psychiatric disorder. Key Takeaways: Compared to healthy controls, schizophrenia patients showed altered activity in brain regions involved in processing …
Depression is a growing mental health concern, especially among young adults. New AI-powered research offers a rapid, objective screening tool to identify those at high risk using eye tracking technology. This innovative approach could revolutionize early detection and intervention. Key Facts: Depression is the leading cause of disability worldwide, often starting in young adulthood. Early …
